CTLA4 and atherosclerosis: Consistent with this observation, in low-density lipoprotein receptor-deficient (Ldlr−/−) mice receiving a hypercholesterolemic diet, administration of anti-CTLA-4 accelerated atherosclerosis progression by inducing predominantly T cell-driven inflammation and promoting the formation of plaques with larger necrotic cores and reduced collagen content [22].